Russia approves first domestic IV immunoglobulin for pediatric immunodeficiency

Russia's health ministry approved the first domestically produced intravenous immunoglobulin for children with immune disorders, produced by Rostech's Natsimbio. This reduces reliance on imports amid sanctions, but clinical efficacy and supply scale remain unverified.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works